Psychedelic Drug Stocks Surge After Trump Fast-Tracks Reviews and Funding
Shares of psychedelic drug developers rallied sharply in premarket trading on Monday after Donald Trump signed an executive order directing health regulators to accelerate the approval process for psychedelic-based treatments and increase federal research...